Total Payments
$2,141
2024 Payments
$56.48
Companies
11
Transactions
43
Medicare Patients
2,551
Medicare Billing
$586,563
Payment Breakdown by Category
Travel$1,351 (63.1%)
Food & Beverage$790.29 (36.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,351 | 4 | 63.1% |
| Food and Beverage | $790.29 | 39 | 36.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $962.90 | 6 | $0 (2018) |
| Nuvectra Corporation | $620.24 | 2 | $0 (2018) |
| PFIZER INC. | $213.68 | 13 | $0 (2019) |
| Purdue Pharma L.P. | $143.64 | 10 | $0 (2018) |
| Daiichi Sankyo Inc. | $41.70 | 2 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $39.09 | 3 | $0 (2017) |
| Amgen Inc. | $36.29 | 2 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $30.01 | 2 | $0 (2018) |
| Pacira Pharmaceuticals Incorporated | $20.19 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $17.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.48 | 3 | Amgen Inc. ($36.29) |
| 2019 | $34.87 | 2 | Daiichi Sankyo Inc. ($21.28) |
| 2018 | $1,671 | 14 | Stryker Corporation ($962.90) |
| 2017 | $378.94 | 24 | PFIZER INC. ($161.35) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Bone Health | ||||||
| 08/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Bone Health | ||||||
| 02/13/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Pain Management | ||||||
| 04/25/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/29/2019 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Pain Management | ||||||
| 08/13/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Pain Management | ||||||
| 08/11/2018 | Nuvectra Corporation | Algovita (Device) | Travel and Lodging | In-kind items and services | $562.60 | General |
| Category: IMPLANTED SPINAL-CORD STIMULATOR FOR PAIN RELIEF | ||||||
| 07/30/2018 | Nuvectra Corporation | Algovita (Device) | Food and Beverage | In-kind items and services | $57.64 | General |
| Category: IMPLANTED SPINAL-CORD STIMULATOR FOR PAIN RELIEF | ||||||
| 06/22/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/23/2018 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Sleep | ||||||
| 04/20/2018 | Stryker Corporation | IVS - IVAS (Device) | Food and Beverage | Cash or cash equivalent | $125.53 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/07/2018 | Stryker Corporation | IVS - NEW PRODUCT DEVELOPMENT (Device) | Travel and Lodging | Cash or cash equivalent | $164.87 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/07/2018 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Food and Beverage | Cash or cash equivalent | $32.30 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/07/2018 | Stryker Corporation | IVS - NEW PRODUCT DEVELOPMENT (Device) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 04/02/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/07/2018 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Travel and Lodging | Cash or cash equivalent | $583.19 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 03/07/2018 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 03/06/2018 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/22/2018 | Purdue Pharma L.P. | OXYCONTIN (Drug), SYMPROIC, HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/14/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $2.07 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/30/2017 | Purdue Pharma L.P. | SYMPROIC (Drug), HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: CONSTIPATION | ||||||
| 10/16/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/21/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/11/2017 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/07/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 493 | 2,654 | $410,733 | $122,109 |
| 2022 | 13 | 568 | 2,761 | $439,638 | $143,514 |
| 2021 | 15 | 653 | 3,104 | $475,165 | $153,843 |
| 2020 | 18 | 837 | 3,340 | $674,450 | $167,097 |
Total Patients
2,551
Total Services
11,859
Medicare Billing
$586,563
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 729 | $164,778 | $61,014 | 37.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 20 | 104 | $114,400 | $17,186 | 15.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 20 | 36 | $39,600 | $11,148 | 28.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 22 | 44 | $15,148 | $7,386 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $21,046 | $7,379 | 35.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 23 | 41 | $20,468 | $6,864 | 33.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 15 | 24 | $15,000 | $4,226 | 28.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 21 | 43 | $10,277 | $3,744 | 36.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 14 | 23 | $4,987 | $1,809 | 36.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 24 | $3,888 | $1,073 | 27.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 33 | 192 | $480.00 | $148.69 | 31.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 39 | 1,323 | $661.50 | $129.72 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 732 | $118,673 | $61,923 | 52.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 32 | 154 | $169,400 | $26,964 | 15.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 32 | 52 | $57,200 | $16,602 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $21,000 | $9,683 | 46.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 24 | 40 | $13,200 | $7,260 | 55.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 20 | 37 | $17,205 | $6,884 | 40.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 13 | 24 | $15,000 | $4,285 | 28.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 24 | 40 | $9,560 | $3,936 | 41.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 13 | 14 | $7,000 | $2,052 | 29.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 12 | 23 | $4,370 | $1,872 | 42.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 27 | 36 | $5,832 | $1,736 | 29.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 43 | 218 | $545.00 | $192.37 | 35.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 40 | 1,307 | $653.50 | $124.71 | 19.1% |
About Dr. Noadia Worku, D.O
Dr. Noadia Worku, D.O is a Pain Medicine healthcare provider based in Monticello, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2011. The National Provider Identifier (NPI) number assigned to this provider is 1053601575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Noadia Worku, D.O has received a total of $2,141 in payments from pharmaceutical and medical device companies, with $56.48 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Travel and Lodging" ($1,351).
As a Medicare-enrolled provider, Worku has provided services to 2,551 Medicare beneficiaries, totaling 11,859 services with total Medicare billing of $586,563. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Monticello, AR
- Active Since 04/18/2011
- Last Updated 07/29/2024
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1053601575
Products in Payments
- IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) $655.49
- Algovita (Device) $620.24
- IVS - NEW PRODUCT DEVELOPMENT (Device) $181.88
- IVS - IVAS (Device) $125.53
- LYRICA (Drug) $110.80
- EMBEDA (Drug) $102.88
- HYSINGLA ER (Drug) $57.69
- OXYCONTIN (Drug) $46.55
- Morphabond ER (Drug) $41.70
- EVENITY (Biological) $36.29
- Horizant (Drug) $30.01
- Xtampza ER (Drug) $28.68
- BUTRANS (Drug) $22.07
- Iovera (Device) $20.19
- ZECUITY (Drug) $17.85
- SYMPROIC (Drug) $17.33
- SUBSYS (Drug) $15.36
- XTAMPZA ER (Drug) $10.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.